Evonik Stock - restructuring plan with 3,200 job cuts unsettles market

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 21:56 CET. Details in the imprint.

Evonik (DE000EVNK013) has presented a far-reaching restructuring program that includes 3,200 job cuts worldwide and the exit from its polyester business by 2027. The plan, reported by outlets such as AFP and Investing.com, has met with a cautious response from investors.

What the restructuring includes

According to an Investing.com report, Evonik plans to cut 3,200 jobs worldwide between 2027 and the end of 2029, including about 2,150 positions in Germany. The measures correspond to roughly 10% of the workforce.

The company also intends to wind down its global polyester business by 2027, exiting sites in Witten, Marl and Shanghai that together generate around EUR 150 million in annual revenue but have been loss-making. Management cites weak demand, geopolitical uncertainty and stronger international competition.

How the chart looks after the news

Investing.com notes that Evonik shares recently traded around EUR 15.40, down roughly 2.5% on the day of the announcement and clearly below the 52-week high of EUR 18.43. That places the stock in the lower half of its one-year range.

On the Frankfurt market, indicative quotes around EUR 15.35 to EUR 15.38 were reported intraday, underlining the muted reaction but not a disorderly selloff. For chart watchers, this keeps Evonik shares near levels seen during previous sector weakness in European chemicals.

How Evonik earns its money

Evonik is a specialty chemicals group that focuses on high-margin applications in areas such as nutrition, care products, additive manufacturing and performance materials. Its portfolio spans additives for animal feed, cosmetic ingredients, high-performance polymers and silica used in tires and coatings.

Where the stock trades today

The shares of Evonik (DE000EVNK013) trade on Xetra at EUR 15.36 as of 06/18/2026, 17:35 CET.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.